NewsRx

Search our medical news database

Medical Technology

FDA clearances granted for software to review multi-detector CT chest exams

Published in Cancer Weekly, July 27th, 2004

R2 Technology, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to market two software packages for use with the ImageChecker CT system during review of multi-detector CT (MDCT) chest exams.

One FDA clearance covers the Temporal Comparison software module, providing the ability to automatically track lung nodule progression or regression over time. Growth rate is one important indicator of clinical significance of the finding and automating this process has potential for significant time savings. The second clearance is for the Filling Defect Indicator software module, designed to help physicians visualize and evaluate filling...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook